Delivering Safely, Securely, and On Time
As part of our full-service model, we manage the distribution of high-risk, high-value therapies across the UK and Europe. This includes managing temperature-sensitive products, ensuring full batch traceability, and meeting all Good Distribution Practice (GDP) requirements.
Regulatory-Compliant Distribution
Our capabilities include:
GDP-compliant warehousing and packaging operations
Cold chain and ambient logistics with 24/7 monitoring
Coordination with hospital pharmacies and specialty logistics partners
Emergency supply services for critical patient cases
We ensure that every therapy reaches its destination in optimal condition — because in rare disease care, every dose counts.
Regulatory-Compliant Distribution
Ensuring Safe, Secure, and Compliant Delivery of Life-Changing Therapies
At Aegerion Pharmaceuticals UK, regulatory-compliant distribution is at the core of how we deliver high-impact therapies to patients living with rare and serious diseases. In the orphan drug space, where precision, safety, and reliability are non-negotiable, our distribution strategy is built on rigorous standards, deep expertise, and a commitment to regulatory excellence.
A Framework Built on Trust and Compliance
Every medicine we deliver is handled with the utmost care, adhering to all applicable UK, EU, and global regulatory frameworks. We ensure compliance with:
Good Distribution Practice (GDP) guidelines
MHRA and EMA regulations
Cold chain management protocols for temperature-sensitive therapies
Pharmacovigilance reporting requirements linked to product delivery
We work only with audited, licensed partners to ensure full integrity and traceability throughout the supply chain—from manufacturing sites to healthcare providers to patients.
Specialized Logistics for Orphan Therapies
Orphan drugs often require specialized handling and delivery infrastructure. Aegerion Pharmaceuticals UK partners with best-in-class distribution providers to ensure:
Controlled-temperature storage and shipping
Real-time shipment tracking to prevent delays or product degradation
Rapid response logistics to meet urgent or hospital-critical needs
Customs and regulatory clearance management for global or early access supply
Our logistics model ensures that even therapies intended for ultra-rare conditions reach their destination securely and on time, no matter how dispersed the patient population may be.
Patient-Centered Distribution Models
Our distribution strategy is built around the unique needs of rare disease patients, who may rely on:
Home delivery options for convenience and privacy
Dispensing via specialist pharmacies with expertise in rare therapies
On-demand clinical delivery in cases of hospital-only access or urgent care
Each model is implemented with full compliance to safety and traceability standards, ensuring that patients receive their medication in a safe, timely, and seamless manner.
Integrated with Access and Compliance Teams
Our distribution system is fully integrated with our broader Access & Compliance infrastructure, including:
Pharmacovigilance systems to track and report any safety concerns post-distribution
Medical Affairs and Quality teams ensuring product integrity from production to patient
Audit readiness and documentation systems to support inspection and reporting
This integrated approach allows us to maintain quality assurance across the entire product lifecycle, supporting our reputation for reliability and accountability in the rare disease space.
Our Distribution Promise
For patients living with rare diseases, access to medicine is more than just a supply chain—it’s a lifeline. At Aegerion Pharmaceuticals UK, we take this responsibility seriously, delivering therapies with the care, compliance, and control that rare disease treatment demands.
Whether supporting hospital pharmacies, specialty distributors, or patients directly, we bring together precision, compliance, and compassion in every delivery.
For more information about our distribution network or to speak with a member of our compliance team, please contact us.
Patient Access & Support Programs
Removing Barriers Between Patients and Life-Changing Treatments
For patients with rare diseases, access can be the single most critical component of care. Aegerion provides a range of programs and services designed to reduce delays, improve adherence, and help patients and families navigate the healthcare system.
